baber/WOPTO huggingface dataset:
Patent NZ-538628-A (NZ)
Title: Immunomodulatory compositions, methods of making, and methods of use thereof
Inventor: VAN NEST GARY
IPC: A61K47/42
Filed: 2003-08-12
Abstract: Disclosed are immunomodulatory compositions comprising immunomodulatory particles, said particulate composition made by mixing a cationic condensing agent; and immunomodulatory compound comprising the nucleotide sequence 5'-CG-3'; and a nonioninc detergent. Also disclosed is the use of the above compositions for modulating immune response.
Patent NZ-539471-A (NZ)
Title: Air drying waterborne resin composition
Inventor: HAGGMAN BO
IPC: C08L101/00
Filed: 2003-10-16
Abstract: An air drying waterbome resin composition comprising at least one amphiphilic air drying dendritic polymer, at least one non-amphiphilic air drying resin, at least one drier initiating and/or promoting autoxidation, water and optionally at least one anionic and/or non-ionic surfactant and/or at least one coalescent agent, characterised in that said at least one amphiphilic air drying dendritic polymer is built up from a polyhydric dendritic core polymer having at least 4 terminal hydroxyl groups and thus a hydroxyl functionality (f) of at least 4, such as 8, 16 or 32, and at least one unsaturated carboxylic acid bonded to at least one and at most f-1 said terminal hydroxyl group(s) and at least one adduct, obtained by addition of at least one monoalkylated polyethylene glycol to at least one dicarboxylic acid or at least one corresponding anhydride and/or at least one diisocyanate, bonded to at least one and at most f-1 said terminal hydroxyl group(s), and that said at least one non amphiphilic air drying resin is an air drying alkyd resin.
Patent NZ-539486-A (NZ)
Title: Container
Inventor: GIVIDEN MICHAEL PAUL
IPC: B65D85/72
Filed: 2003-08-06
Abstract: Infused liquid beverages are made from infusion bags (for example tea bags) having a string and tag attached in a container comprising a receptacle for holding the infusing liquid, a lid for the receptacle provided with an opening having a first portion which is capable of gripping the string of the infusion bag and a second portion through which the string of the infusion bag can move into and out of the container.
Patent NZ-540608-A (NZ)
Title: Improved drive signal generator
Inventor: DUBOVSKIY VLADIMIR
Filed: 2005-06-07
Abstract: A method of determining a drive signal to drive the output state of a system to a desired output comprises determining the order of the system and receiving an arbitrary input signal representative of a desired output state of the system. A sampling period is determined and the sampling period is divided into a number of consecutive time epochs. The number of time epochs formed is one greater that the order determined for the system. A further terminal time epoch is added to the sampling period and a value is associated with the terminal time epoch equivalent to the input signal received. A piecewise drive signal is determined by i) calculating for each time epoch a function component and ii) assembling a drive signal from a piece wise combination of the signal function components calculated. The assembled drive signal is supplied to the system to drive its output to the desired output state.
Patent NZ-551908-A (NZ)
Title: Methods and compositions for modulating hepatocyte growth factor HGF activation
Inventor: KIRCHHOFER DANIEL K
IPC: C12Q1/37
Filed: 2005-07-25
Abstract: Disclosed is a method for identifying a candidate inhibitor substance that inhibits hepsin activation of HGF. Further disclosed is the use of an antagonist molecule that inhibits pro-HGF activation by hepsin and is capable of binding to pro-HGF or hepsin in the preparation of a medicament for the treatment of a pathological condition associated with activation of c-met such as cancer or a cell proliferative disorder.
Patent NZ-552845-A (NZ)
Title: Multiparticulates of preferably an opioid, and method of manufacturing using extrusion
Inventor: HAYES GEOFFREY GERARD
IPC: B29C48/63
Filed: 2005-08-31
Abstract: Disclosed are melt extruded, controlled release multiparticulates containing a pharmaceutically active agent, an insoluble ammonium methacrylate copolymer, a water permeability modifier and a non-dominating plasticiser, substantially free of dominating or non-dominating lubricants selected from stearic acid, glyceryl behenate, magnesium stearate, calcium stearate, talc or silicone dioxide (fused silica), wherein the water permeability modifier is chosen from an insoluble hydrophilic wicking agent, a gelling agent which hydrates to form a gel to control the water movement, a high molecular weight polyethylene glycol, or a water permeable ammonium methacrylate copolymer, and wherein the amount of non-dominating plasticiser is 10 to 20 percent based on the total weight of ingredients. Also disclosed is a unit dose comprising said multiparticles, a process for preparing said multiparticles and the use of the unit dose in the treatment of analgesia.
Patent NZ-554131-A (NZ)
Title: Serum-free cell culture medium for mammalian cells
Inventor: CASATORRES HERNANDEZ JOSE
IPC: C12N5/02
Filed: 2005-10-28
Abstract: Provided is a process for the production of growth hormone comprising the step of culturing cells of a cell line expressing growth hormone in a cell culture medium free of components derived from animal serum, the medium comprising Zinc in a concentration ranging from 0.2 microM to 1.75 microM and Copper in a concentration ranging from 10 nM to 75 nM and Ferric ions in a concentration ranging from 1 to 10 microM. Further provided are similar processes with specified media and promoters controlling expression and use of the media for the production of growth hormone.
Patent NZ-561759-A (NZ)
Title: Viral diagnostic method and well for use in same
Inventor: ALEXANDER ROBERT
IPC: B01L3/00
Filed: 2006-03-10
Abstract: Disclosed is a single flat-based well suitable for use in a viral detection assay, the well comprising: i. a main chamber having side walls, a base and an opening to receive a liquid sample, the side walls which extend from the opening to a chamber base; and ii. a sub-chamber extending below the chamber base of the main chamber adapted to receive a predetermined amount of the liquid sample, wherein the sub-chamber has a flat base, wherein the sub-chamber and main chamber take any suitable form including a circular, square, triangular or hexagonal cross section with the sub-chamber having different sized and shaped cross section relative to the main chamber to reduce or eliminate a meniscus. Further disclosed is a well unit comprising multiple single flat-based wells and methods of use thereof.
Patent NZ-566584-A (NZ)
Title: Eyewear with eye shield formed by chemical etching
Inventor: HALL PHILLIP DAVID
IPC: A42B3/00
Filed: 2008-03-11
Abstract: Eyewear 1 includes an eye shield 2 of a mesh 3 of hexagonal apertures chemically etched through a thin sheet of stainless steel or plastics material. A safety visor including an eye/face shield of a mesh with hexagonal apertures etched in a thin sheet of stainless steel material is described in NZ 515436 for example, but the etching is not disclosed in the earlier published document to be "chemical" as claimed in this application.
Patent NZ-580165-A (NZ)
Title: Therapeutic agent for glaucoma containing adenosine derivative as active ingredient
Inventor: SHIMAZAKI ATSUSHI
IPC: A61K31/70
Filed: 2008-04-14
Abstract: Use of a compound represented by the general formula (1) e.g. 4-{ 3-[6-amino-9-((2R,3R,4S,5S)-5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl]-2-propynyl} -piperidine-1-carboxylic acid methyl ester or a salt thereof for producing a preventive or therapeutic agent for glaucoma or ocular hypertension wherein the variables are defined in the specification.
Patent NZ-585829-A (NZ)
Title: Hydrolysis resistant organomodified trisiloxane ionic surfactant compositions and aqueous emulsion thereof
Inventor: LEATHERMAN MARK D
IPC: C09K23/54
Filed: 2008-12-26
Abstract: An asymmetric organo-modified disiloxane surfactant having the formula: M1DM2 is disclosed, wherein M1 = (R1)(R2)(R3)SiO1/2; M2 = (R4)(R5)(R6) SiO1/2 and D = (R7)(Z) SiO2/2 where R1, R2, R3, R4, R5, R6 and R7 are each independently selected from the group consisting of 1 to 4 carbon monovalent hydrocarbon radicals, aryl, and a hydrocarbon group of 4 to 9 carbons containing an aryl group; Z is a pendant hydrophilic ionic group selected from the group consisting of R8-RA, R9 Rc, and R10-Rz; ; RA being an anionic substituent, Rc a cationic substituent or Rz a zwitterionic substituent on the D group, which are further defined in the specification, wherein the disiloxane surfactant has an enhanced resistance to hydrolysis between a pH of about 3 to about 12. The disclosure also relates to a composition comprising said asymmetric organo-modified disiloxane surfactant and a component selected from the group consisting of agricultural components, coating components, personal care components, home care components, oil or gas treating components, water processing components, and pulp or paper treating components. Further disclosed are aqueous emulsions where the discontinuous phase comprises water and the continuous phase comprises said composition mixture, or vice versa.
Patent NZ-587060-A (NZ)
Title: Rna interference for the treatment of heart failure
Inventor: HAJJAR ROGER J
IPC: A61P9/00
Filed: 2008-12-23
Abstract: Disclosed is the use of a vector comprising an RNAi expression cassette having a nucleotide sequence as set forth in SEQ ID NO:1, and whose expression product decreases expression or activity of phospholamban (PLB), in the manufacture of a medicament suitable for treating heart failure.
Patent NZ-587202-A (NZ)
Title: Methods for measuring a patient response upon administration of a drug and compositions thereof
Inventor: SCHACHTEL BERNARD P
IPC: A01N37/10
Filed: 2009-01-05
Abstract: 587202 Disclosed is the use of (a) an analgesic potentiating compound and (b) an analgesic compound in the manufacture of a medicament to treat pain by potentiating the analgesic properties of said analgesic compound, wherein (i) the analgesic compound is an analgesic effective amount of a compound selected from the group consisting of ibuprofen, or the pharmaceutically acceptable salt or isomer thereof, at a dosage from 100 mg to 800 mg of the composition, and (ii) the analgesic potentiating compound is a compound selected from the group consisting of nizatidine, or the pharmaceutically effective salt or isomer thereof at a dosage from 10 mg to 200 mg of the composition, and wherein the medicament is formulated for separate, sequential or simultaneous administration of (a) and (b).
Patent NZ-590833-A (NZ)
Title: Genetic variants for breast cancer risk assessment
Inventor: STACEY SIMON
IPC: C12Q1/68
Filed: 2009-07-03
Abstract: 590833 Disclosed is a method for determining a susceptibility to breast cancer in a human individual, comprising determining whether at least one allele of at least one polymorphic marker is present in a nucleic acid sample from the individual or in a genotype dataset from the individual, wherein the at least one polymorphic marker is selected from the group consisting of rs999737 (SEQ ID NO:6), and markers in linkage disequilibrium therewith, wherein linkage disequilibrium between markers is characterized by values of r2 of at least 0.2, and wherein determination of the presence of the at least one allele is indicative of a susceptibility to breast cancer for the individual. Further disclosed is a computer program for determining a genetic indicator for breast cancer in a human individual: wherein the computer program is adapted to be executed on the processor to analyze marker and/or haplotype information for at least one human individual with respect to at least one polymorphic marker selected from rs999737 (SEQ ID NO:6), and markers in linkage disequilibrium therewith, wherein linkage disequilibrium is characterized by values of r2> 0.2, and generate an output based on the marker or haplotype information, wherein the output comprises a risk measure of the at least one marker or haplotype as a genetic indicator of breast cancer for the human individual.
Patent NZ-591237-A (NZ)
Title: A device for the utilisation of wave energy using darrieus and wells rotors
Inventor: SCHEIJGROND PETER CORNELIS
IPC: F03B17/06
Filed: 2009-07-21
Abstract: The disclosure relates to a device for the utilisation of wave energy, with an increased efficiency. Thereto, the device according to the invention comprises - a Darrieus rotor having at least two Darrieus rotor blades, wherein the Darrieus rotor has a solidity sD, and - a Wells rotor having at least two Wells rotor blades, wherein the Wells rotor has a solidity sW, wherein - the Darrieus rotor and the Wells rotor are rotatable about a common axis of rotation A, and - sW is larger than or equal to sD. The disclosure also relates to a method for harnessing wave energy.
Patent NZ-593180-A (NZ)
Title: Zeaxanthin alone or combined with either rutin or spermidine, or both rutin and spermidine for treating scalp disorders
Inventor: GIULIANI GIAMMARIA
IPC: A61K31/047
Filed: 2009-10-30
Abstract: Disclosed is the use of zeaxanthin and/or rutin, as such or further combined with spermidine, as the active principle in a pharmaceutical, dietary, or cosmetic composition, acting to inhibit caspase-3 and therefore to control apoptosis by preventing programmed cell death. The indication for this composition according to the invention is primarily the treatment of scalp disorders characterized by excessive cellular turnover including chemotherapy-induced alopecia, alopecia areata, androgenetic alopecia and telogen effluvium.
Patent NZ-593196-A (NZ)
Title: Method for removing residues of hazardous materials from vapour in a tank
Inventor: VAN DER BOGT PERRY
IPC: B08B7/00
Filed: 2009-11-05
Abstract: 593196 Method and apparatus for removing residues of hazardous materials from vapour in a tank (1), wherein such a vapour is heated, passed outside the tank and subsequently cooled and the remaining dry vapour is recirculated, characterized in that a) said vapour is heated to a temperature of at least 5 DEGREE C above the melting point and below the self-ignition point of the hazardous material, b) the vapour mixture thus formed is passed by means of a pump (3) from the tank through a discharge unit to a recovery unit, c) is cooled to a temperature of at least 5 DEGREE C lower and above the melting point of the hazardous material in a recovery unit, d) the liquid components of the vapour are recovered and the dry gas mixture is recirculated to the tank after reheating to the desired temperature, e) said recirculation being repeated as required.
Patent NZ-602192-A (NZ)
Title: Three-dimensional goods storage arrangement in which the space taken up by the goods is reduced in relation to the goods storage capacity
Inventor: LINDBLOM BO
IPC: B65G1/04
Filed: 2011-02-28
Abstract: Disclosed is a three-dimensional goods storage arrangement in which the space taken up by the goods is reduced in relation to the goods storage capacity. The arrangement comprises a system of beams; first (3) and second (6, 6’, 6’’, 6’’’, 6’’’’) passages/channels; first transport elements; second transport elements and control elements and sensors. The system of beams comprises two or more levels (2) and are arranged extending in a first main direction (5) and a second main direction (7). The passages/channels (3, 6, 6’, 6’’, 6’’’, 6’’’’) are for goods (10, 11, 12, 13). The first transport elements are in the form of one or more lifts (9) which are applied to the system of beams. The lifts (9) are movable between levels (2). The second transport elements transport to and from selected locations in the passages/channels (3, 6, 6’, 6’’, 6’’’, 6’’’’) for the goods (10, 11, 12, 13). The control elements and sensors control the first and second transport elements. The first passage/channel (3) is provided with a first path or track and a carriage (4). The carriage (4) belongs to the second transport elements and comprises first drive elements. The drive elements allow the carriage (4) to be driven on the first path or track to allow the carriage (4) to position itself in line with a number of second passages or channels (6, 6’, 6’’, 6’’’, 6’’’’). The second passages or channels (6, 6’, 6’’, 6’’’, 6’’’’) are provided with second paths or tracks. One or more satellites (8) are provided and each comprises a second drive element. Each satellite (8) can be driven on each second path or track. The carriage (4) has support elements for each satellite (8) so it can be driven on or off the carriage (4).
Patent NZ-616046-A (NZ)
Title: An electrical plug and socket
Inventor: JEREMY CHARLES GRAY
IPC: H01R107/00
Filed: 2013-09-27
Abstract: 616046 A male electrical plug and socket (101) for computer-controlled light fittings are disclosed. The plug has five pins. Three of the pins (2, 3 and 4) are conventional active, neutral and earth pins and two of the pins (105, 106) are auxiliary pins. The auxiliary pins (105, 106) are located either side of said earth pin (4) and are of the same construction or shape as the active and neutral pins (2, 3). A matching socket with five apertures is also disclosed.
Patent NZ-619222-A (NZ)
Title: Cellular communication system support for limited bandwidth communication devices
Inventor: LINDOFF BENGT
IPC: H04W48/12
Filed: 2012-06-21
Abstract: Disclosed is a communication system node that transmits first control channel information on a control channel that extends over a first bandwidth of a radio frequency resource. The first control channel information is necessary to enable a first type of communication device, capable of receiving a signal having the first bandwidth, to establish a connection with a host cell. A Master Information Block (MIB), occupying a second bandwidth-size part of the first bandwidth, is transmitted. The second bandwidth is smaller than the first bandwidth and is receivable by a second type of communication device having reduced receive bandwidth capabilities. The MIB has a first part comprising first part information necessary to enable the first type of communication device to establish the connection with the host cell, and a second part comprising second part information directly or indirectly enabling the second type of communication device to obtain parameters that enable connection establishment with the host cell.
Patent NZ-620826-A (NZ)
Title: Nucleic acid purification
Inventor: SELDEN RICHARD F
IPC: G01N1/34
Filed: 2010-02-03
Abstract: Disclosed is a self-contained apparatus for generating a cell lysate from a biological sample. The self-contained apparatus may be a cartridge. The self-contained apparatus is to be used with an instrument. The self-contained apparatus comprises a macrofluidic component (3) and a microfluidic component (4) in communication with the macrofluidic component via at least one microfluidic element. The microfluidic component further includes a nucleic acid purification matrix. The macrofluidic component comprises a chamber (see 16, figure 4), for receiving an unprocessed biological sample from a collection device (1), and at least one pre-filled reagent storage reservoir (see 6-15, figure 4). The self-contained apparatus only comprises two inputs; one being the aforementioned chamber, for receiving the sample from a collection device, and the other input being a pneumatic interface port (5). In use, a drive mechanism of the instrument provides pneumatic pressure through the pneumatic interface port to drive reagents from the at least one reagent storage reservoir through the microfluidic element and the nucleic acid purification matrix and back into another microfluidic chamber. The self-contained apparatus provides a simple means for generating a cell lysate that eliminates the need for trained, technical users, working in sophisticated laboratories. Also, as the reagents are contained within the apparatus the risk of a user contaminating the reagent is avoided. A method for generating cell lysate from an unprocessed sample is also disclosed.
Patent NZ-621016-A (NZ)
Title: Method for reading vehicle identifications
Inventor: OLIVER NAGY
IPC: G07B15/06
Filed: 2014-02-11
Abstract: 621016 Method of reading license plate numbers using optical character recognition (ORC) in a road network is disclosed. The method comprises: first, recording and OCR reading an image of a license plate number at a first location, and storing the OCR data set including this license plate number, character string from OCR reading and confidence measurements. Secondly, recording and OCR reading an image of a license plate number at a second location, and generating confidence measurements. Finally, testing if at least one confidence measure of the current OCR data set falls below a first minimum confidence value, if so, then select the stored OCR data sets which similar to the current OCR data set from the database, and using at least one selected OCR data set for improving the license plate number character string of the current OCR data set.
Patent NZ-624524-A (NZ)
Title: Radio base station with asymmetric interface between baseband unit and rf unit
Inventor: Göransson Bo
IPC: H04W88/08
Filed: 2011-12-15
Abstract: The invention relates to an integrated antenna node (22) for use in wireless communication in a communication system (20), the wireless communication involving uplink and downlink physical-layer processing. The integrated antenna node (22) is adapted to perform, for at least one set of corresponding uplink and downlink physical-layer processing functions, only the uplink physical-layer processing functions or the corresponding downlink physical-layer processing functions. The invention further relates to a main node (21), a radio base station (28), computer programs and computer program products.
Patent NZ-701296-A (NZ)
Title: Unsaturated fatty alcohol alkoxylates from natural oil metathesis
Inventor: BERNHARDT RANDAL J
IPC: C09D7/45
Filed: 2013-03-13
Abstract: Unsaturated fatty alcohol alkoxylates, processes for making them, and methods of using them are disclosed. In one aspect, a monounsaturated fatty alcohol alkoxylate is made by reducing a metathesis-derived monounsaturated alkyl ester, followed by alkoxylation of the resulting monounsaturated alcohol. Microscopy reveals that the monounsaturated alkoxylates have isotropic and lamellar phases over a wider range of actives levels compared with their saturated analogs. This attribute expands formulating latitude for many end-use applications. The unsaturated fatty alcohol alkoxylates are valuable in, for example, agricultural solvents, nonionic emulsifiers for agricultural compositions, hard surface cleaners, laundry detergents, specialty foams, additives or surfactants for paints or coatings, and surfactant compositions for enhanced oil recovery.
Patent NZ-703258-A (NZ)
Title: Use of a cream that protects against the effects of aggressive chemical agents in contact with the skin
Inventor: BLOMET JOëL
IPC: A61P17/16
Filed: 2013-07-17
Abstract: The present invention relates to the use of an emulsion for protecting the skin against aggressive chemical agents, wherein this emulsion comprises at least one amphoteric chelating agent which comprises a complex based on aluminium and on ethylenediaminetetraacetic acid or the trisodium salt thereof, having the general formula [Al (Y) Bn] C’Dc with B being OH-,BO2 or H-, Y being a tetracarboxylate which can be protonated four times to form ethylenediaminetetraacetic acid, n being an integer equal to 0, 1, 2 or 3, D being a counterion, preferably Na+, c being an integer equal to 0, 1, 2 or 3 and c’ being a relative number having the same absolute value as c.